Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2022-05-18 2022-05-17
Drug Identification Number 01978918 01978918
Brand name PULMICORT NEBUAMP 0.25 MG/ML PULMICORT NEBUAMP 0.25 MG/ML
Common or Proper name budesonide budesonide
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients BUDESONIDE BUDESONIDE
Strength(s) 0.25MG 0.25MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 20 ampoules 20 ampoules
ATC code R03BA R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-05-03 2022-05-03
Actual start date 2022-05-03 2022-05-03
Estimated end date 2022-05-19 2022-05-19
Actual end date 2022-05-17 2022-05-17
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments